AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Axogen, Inc. Common Stock
XNAS · usd
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG001S5SRD1
38.06▲ 1.38 (3.76%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
36.68
Day's Range
36.60 – 38.33
52-Week Range
17.14 – 52.91
Volume
2.1M
Avg Volume
1.4M
Share Statistics
Shares Outstanding
Employees
622
Exchange
XNAS
Listed
1986-12-17
Share count as of July 27, 2026

Axogen, Inc. Common Stock (AXGN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Axogen, Inc. Common Stock (AXGN)
What is Axogen, Inc. Common Stock's Market Cap?
Axogen, Inc. Common Stock's Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's Enterprise Value?
Axogen, Inc. Common Stock's Enterprise Value is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's Price / Sales?
Axogen, Inc. Common Stock's Price / Sales is 8.1×, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's EV / Revenue?
Axogen, Inc. Common Stock's EV / Revenue is 7.7×, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's EV / EBITDA?
Axogen, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's Revenue (TTM)?
Axogen, Inc. Common Stock's Revenue (TTM) is $251.2M, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's Net Income (TTM)?
Axogen, Inc. Common Stock's Net Income (TTM) is -$33.5M, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's EBITDA?
Axogen, Inc. Common Stock's EBITDA is -$6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's Diluted EPS (TTM)?
Axogen, Inc. Common Stock's Diluted EPS (TTM) is -0.62, based on as-reported figures from SEC (XBRL) filings.
What is Axogen, Inc. Common Stock's EBITDA Margin?
Axogen, Inc. Common Stock's EBITDA Margin is -2.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · AXGNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth+23.1%+26.6%+21.3%+23.5%
Cost of goods sold
Gross profit
% of revenue72.7%75.2%74.1%76.6%
Costs and expenses
Sales and marketing
Research and development
General and administrative
Total costs and expenses
% of revenue75.8%79.8%90.4%73.4%
(Loss) income from operations
% of revenue-3.1%-4.6%-16.3%3.2%
Other income (expense)
Investment income
Interest expense
Loss on extinguishment of debt——
Change in fair value of debt derivative liabilities
Other (expense) income, net
Total other income (expense), net
Net (loss) income
% of revenue-2.2%-31.9%-22.0%1.2%
Net (loss) income per common share - basic (in USD per share)
Net (loss) income per common share - diluted (in USD per share)